UPDATE: Credit Suisse Upgrades Ultragenyx Pharma (RARE) to Outperform
Tweet Send to a Friend
(Updated - March 16, 2022 4:16 AM EDT)
Credit Suisse analyst Martin Auster upgraded Ultragenyx Pharma (NASDAQ: RARE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Credit Suisse analyst Martin Auster upgraded Ultragenyx Pharma (NASDAQ: RARE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
